Annals of neurology

publication venue for

Febrile infection-related epilepsy syndrome treated with anakinra. 2016
Tropical spastic paraparesis: clinical, immunological, and virological studies in two patients from Martinique. 1988
Clinical and magnetic resonance features of primary intracranial arachnoid cysts. 1987
Neurological manifestations of hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber disease): report of 2 cases and review of the literature. 1978
Fostering Academia-Industry Partnerships to Facilitate Therapeutic Discoveries in Neurology: The Role of ANA as a Catalyst. 2024
Strokes Averted by Intravenous Thrombolysis: A Secondary Analysis of a Prospective, Multicenter, Controlled Trial of Mobile Stroke Units. 2023
Intensive Blood Pressure Reduction is Associated with Reduced Hematoma Growth in Fast Bleeding Intracerebral Hemorrhage A Secondary Analysis of the ATACH-2 Randomized Clinical Trial. 2023
A New Advanced MRI Biomarker for Remyelinated Lesions in Multiple Sclerosis. 2022
Prolonged Unconsciousness is Common in COVID-19 and Associated with Hypoxemia.. 91. 2022
Inequities in therapy for infantile spasms: a call to action. 2022
Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.. 90. 2021
Anticoagulation Timing in Cardioembolic Stroke and Recurrent Event Risk.. 88. 2020
Association between Pregnancy and Cervical Artery Dissection.. 88. 2020
Strategic Considerations for Applying the Flipped Classroom to Neurology Education.. 87. 2019
Associations between cerebrovascular risk factors and parkinson disease.. 86. 2019
Reduction of skin innervation is associated with a severe fibromyalgia phenotype.. 86. 2019
Early results of nerve transfers for restoring function in severe cases of acute flaccid myelitis.. 86. 2019
Corneal confocal microscopy: Neurologic disease biomarker in Friedreich ataxia.. 84. 2018
N-acetylcysteine targets 5 lipoxygenase-derived, toxic lipids and can synergize with prostaglandin E₂ to inhibit ferroptosis and improve outcomes following hemorrhagic stroke in mice.. 84. 2018
Effect of sensory and motor connectivity on hand function in pediatric hemiplegia.. 82. 2017
Traumatic brain injury in the prodromal period of Parkinson's disease: A large epidemiological study using medicare data.. 82. 2017
Pyrimethamine significantly lowers cerebrospinal fluid Cu/Zn superoxide dismutase in amyotrophic lateral sclerosis patients with SOD1 mutations.. 81. 2017
Immune activation in amniotic fluid from Zika virus-associated microcephaly.. 81. 2017
Mutation in noncoding RNA RNU12 causes early onset cerebellar ataxia.. 81. 2017
Bedside quantitative electroencephalography improves assessment of consciousness in comatose subarachnoid hemorrhage patients.. 80. 2016
Deep brain stimulation and climbing fiber synaptic pathology in essential tremor.. 80. 2016
Response to treatment in a prospective national infantile spasms cohort.. 79. 2016
Electrocardiographic left atrial abnormality and stroke subtype in the atherosclerosis risk in communities study.. 78. 2015
Gene delivery of neurturin to putamen and substantia nigra in Parkinson disease: A double-blind, randomized, controlled trial.. 78. 2015
Association between incident cancer and subsequent stroke.. 77. 2015
Preservation of electroencephalographic organization in patients with impaired consciousness and imaging-based evidence of command-following.. 76. 2014
Bioenergetic markers in skin fibroblasts of sporadic amyotrophic lateral sclerosis and progressive lateral sclerosis patients.. 76. 2014
Hippocampal sclerosis after febrile status epilepticus: the FEBSTAT study.. 75. 2014
Association of gestational maternal hypothyroxinemia and increased autism risk.. 74. 2013
Genetic deletion of CD36 enhances injury after acute neonatal stroke.. 72. 2012
Inhibition of 12/15-lipoxygenase as therapeutic strategy to treat stroke.. 73. 2012
CD36 in the periphery and brain synergizes in stroke injury in hyperlipidemia.. 71. 2012
Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.. 71. 2012
Can semiology predict psychogenic nonepileptic seizures? A prospective study.. 69. 2011
Disparities in stroke incidence contributing to disparities in stroke mortality.. 69. 2011
YKL-40 and MMP-9 as serum markers for patients with primary central nervous system lymphoma.. 70. 2011
Intracortical electroencephalography in acute brain injury.. 66. 2009
The brain in the age of old: the hippocampal formation is targeted differentially by diseases of late life.. 64. 2008
Postictal psychosis in partial epilepsy: a case-control study.. 63. 2008
Complementary patterns of gene expression by human oligodendrocyte progenitors and their environment predict determinants of progenitor maintenance and differentiation.. 59. 2006
Preclinical Huntington's disease: compensatory brain responses during learning.. 59. 2006
Mitochondrial abnormalities in Alzheimer brain: mechanistic implications.. 57. 2005
The metabolic pathology of dopa-responsive dystonia.. 57. 2005
Effective gene therapy for an inherited CNS disease in a large animal model.. 57. 2005
Glut-1 deficiency syndrome: clinical, genetic, and therapeutic aspects.. 57. 2005
Frequency of catamenial seizure exacerbation in women with localization-related epilepsy.. 56. 2004
PINK1 mutations are associated with sporadic early-onset parkinsonism.. 56. 2004
Microstructural white matter changes in carriers of the DYT1 gene mutation.. 56. 2004
Prostanoids, not reactive oxygen species, mediate COX-2-dependent neurotoxicity.. 55. 2004
Presence of dendritic cells, MCP-1, and activated microglia/macrophages in amyotrophic lateral sclerosis spinal cord tissue.. 55. 2004
Impaired sequence learning in carriers of the DYT1 dystonia mutation.. 54. 2003
Autoantigen diversity in the opsoclonus-myoclonus syndrome.. 53. 2003
Late secondary ischemic injury in patients receiving intraarterial thrombolysis.. 52. 2002
Primary dystonia: is abnormal functional brain architecture linked to genotype?. 52. 2002
Dyskinesia after fetal cell transplantation for parkinsonism: a PET study.. 52. 2002
Rescue of a mitochondrial deficiency causing Leber Hereditary Optic Neuropathy.. 52. 2002
Imaging the metabolic footprint of Glut1 deficiency on the brain.. 52. 2002
Pallidal stimulation for parkinsonism: improved brain activation during sequence learning.. 52. 2002
Deficiency of tetralinoleoyl-cardiolipin in Barth syndrome.. 51. 2002
Charcot-Marie-Tooth disease and related neuropathies: mutation distribution and genotype-phenotype correlation.. 51. 2002
Metabolic changes following subthalamotomy for advanced Parkinson's disease.. 50. 2001
Blinded positron emission tomography study of dopamine cell implantation for Parkinson's disease.. 50. 2001
Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease.. 50. 2001
Differences in sensory and motor cortical organization following brain injury early in life.. 49. 2001
Sequence-selective DNA binding drugs mithramycin A and chromomycin A3 are potent inhibitors of neuronal apoptosis induced by oxidative stress and DNA damage in cortical neurons.. 49. 2001
Functional correlates of pallidal stimulation for Parkinson's disease.. 49. 2001
No evidence for genetic association or linkage of the cathepsin D (CTSD) exon 2 polymorphism and Alzheimer disease.. 49. 2001
Mitochondrial damage in Alzheimer's disease varies with apolipoprotein E genotype.. 48. 2000
Thrombolytic reversal of acute human cerebral ischemic injury shown by diffusion/perfusion magnetic resonance imaging.. 47. 2000
Detection and treatment of activated T cells in the cerebrospinal fluid of patients with paraneoplastic cerebellar degeneration.. 47. 2000
Meningeal cells can communicate with astrocytes by calcium signaling.. 47. 2000
Characterization of mutations in the gene doublecortin in patients with double cortex syndrome.. 45. 1999
Predominance of neuronal mRNAs in individual Alzheimer's disease senile plaques.. 45. 1999
Modulation by DLST of the genetic risk of Alzheimer's disease in a very elderly population.. 45. 1999
Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of amyotrophic lateral sclerosis patients.. 44. 1998
Alpha-ketoglutarate dehydrogenase in Alzheimer brains bearing the APP670/671 mutation.. 44. 1998
Malignant glioma: who benefits from adjuvant chemotherapy?. 44. 1998
Presence of 4-hydroxynonenal in cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis.. 44. 1998
Functional brain networks in DYT1 dystonia.. 44. 1998
Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease.. 44. 1998
[11C]raclopride-PET studies of the Huntington's disease rate of progression: relevance of the trinucleotide repeat length.. 43. 1998
Presurgical multimodality neuroimaging in electroencephalographic lateralized temporal lobe epilepsy.. 42. 1997
Magnetoencephalography in partial epilepsy: clinical yield and localization accuracy.. 42. 1997
Human immunodeficiency virus infection of dorsal root ganglion neurons detected by polymerase chain reaction in situ hybridization.. 42. 1997
Clinical features of neocortical temporal lobe epilepsy.. 40. 1996
Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease.. 39. 1996
Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis.. 39. 1996
Intravenous gamma-globulin inhibits binding of anti-GM1 to its target antigen.. 39. 1996
AIDS dementia complex and HIV-1 brain infection: clinical-virological correlations.. 38. 1995
Leptomeningeal tumor in primary central nervous system lymphoma: recognition, significance, and implications.. 38. 1995
Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis.. 38. 1995
Amyotrophic lateral sclerosis immunoglobulins increase Ca2+ currents in a motoneuron cell line.. 37. 1995
The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis.. 36. 1994
Chromosomal fragility associated with familial Alzheimer's disease.. 36. 1994
Monoclonal IgM antibodies to GM1 and asialo-GM1 in chronic neuropathies cross-react with Campylobacter jejuni lipopolysaccharides.. 35. 1994
Amyotrophic lateral sclerosis patient antibodies label Ca2+ channel alpha 1 subunit.. 35. 1994
A new point mutation of the prion protein gene in Creutzfeldt-Jakob disease.. 34. 1993
The gp120 glycoprotein of human immunodeficiency virus type 1 binds to sensory ganglion neurons.. 34. 1993
Defecatory function in Parkinson's disease: response to apomorphine.. 33. 1993
Cerebral lymphoma presenting as a nonenhancing lesion on computed tomographic/magnetic resonance scan.. 33. 1993
Nigral damage and dopaminergic hypofunction in mesencephalon-immunized guinea pigs.. 32. 1992
Patterns of reactivity of human anti-GM1 antibodies with spinal cord and motor neurons.. 32. 1992
Experimental conduction block induced by serum from a patient with anti-GM1 antibodies.. 31. 1992
Lethal cytomegalovirus infection in preterm infants: clinical, radiological, and neuropathological findings.. 31. 1992
A selective loss of somatostatin in the hippocampus of patients with temporal lobe epilepsy.. 29. 1991
Abnormal cerebral glucose metabolism in long-term survivors of childhood acute lymphocytic leukemia.. 29. 1991
Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.. 29. 1991
Lymphoma, motor neuron diseases, and amyotrophic lateral sclerosis.. 29. 1991
General assay for phosphoproteins in cerebrospinal fluid: a candidate marker for paraneoplastic cerebellar degeneration.. 28. 1990
Increased MEPP frequency as an early sign of experimental immune-mediated motoneuron disease.. 28. 1990
Middle cerebral artery strokes causing homonymous hemianopia: positron emission tomography.. 28. 1990
Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome.. 28. 1990
Detection of the anti-Hu antibody in the serum of patients with small cell lung cancer--a quantitative western blot analysis.. 27. 1990
AIDS-related vacuolar myelopathy is not associated with coinfection by human T-lymphotropic virus type I.. 26. 1989
Experimental autoimmune motoneuron disease.. 26. 1989
Altered glucose metabolism in microvessels from patients with Alzheimer's disease.. 26. 1989
Cerebral blood flow requirement for brain viability in newborn infants is lower than in adults.. 24. 1988
Antibody to human and simian retrovirus, HTLV-I, HTLV-II, HIV, STLV-III, and SRV-I not increased in patients with multiple sclerosis.. 23 Suppl. 1988
HTLV-I-associated tropical spastic paraparesis in Martinique: a reappraisal.. 23 Suppl. 1988
Long-term administration of 3'-azido-2',3'-dideoxythymidine to patients with AIDS-related neurological disease.. 23 Suppl. 1988
The AIDS dementia complex: some current questions.. 23 Suppl. 1988
The neuroepidemiology of tropical spastic paraparesis.. 23 Suppl. 1988
A rating scale for amyotrophic lateral sclerosis: description and preliminary experience.. 22. 1987
The effect of hyperosmotic blood-brain barrier disruption on blood-to-tissue transport in ENU-induced gliomas.. 22. 1987
Generation of human B-cell hybridomas secreting monoclonal anti-myelin-associated glycoprotein antibodies from a patient with neuropathy.. 21. 1987
Cerebral glucose metabolism in the Lennox-Gastaut syndrome.. 21. 1987
Cerebrospinal fluid pharmacokinetics of intrathecal morphine sulfate and D-Ala2-D-Leu5-enkephalin.. 20. 1986
Autoimmune response of patients with paraneoplastic cerebellar degeneration to a Purkinje cell cytoplasmic protein antigen.. 18. 1985
Immunofluorescence study of patients with neuropathy and IgM M proteins.. 18. 1985
Neuropathy and anti-myelin-associated glycoprotein IgM M proteins: T cell regulation of M protein secretion in vitro.. 18. 1985
An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain.. 17. 1985
Tropical spastic paraparesis: a neuroepidemiological study in Colombia.. 17. 1985
Positron emission tomography in the asphyxiated term newborn: parasagittal impairment of cerebral blood flow.. 17. 1985
Evolution of computed tomographic abnormalities in leptomeningeal metastases.. 17. 1985
Regional blood flow in ethylnitrosourea-induced brain tumors.. 14. 1983
Regional blood-to-tissue transport in ethylnitrosourea-induced brain tumors.. 14. 1983
Polyneuropathy in nonmalignant IgM plasma cell dyscrasia: a morphological study.. 14. 1983
Induction of brain edema following intracerebral injection of arachidonic acid.. 13. 1983
Cerebrospinal fluid monoamine metabolites in narcolepsy and hypersomnia.. 13. 1983
Central nervous system excitatory effects of meperidine in cancer patients.. 13. 1983
Interaction of myasthenic immunoglobulins and cholinergic agonists on acetylcholine receptors of rat myotubes.. 11. 1982
A unifying hypothesis for the cause of amyotrophic lateral sclerosis, parkinsonism, and Alzheimer disease.. 10. 1981
Myotonic dystrophy: calcium-dependent phosphatidic acid synthesis in erythrocytes.. 10. 1981
Radiation-induced malignant and atypical peripheral nerve sheath tumors.. 7. 1980
Neonatal myasthenia gravis in the infant of a myasthenic mother in remission.. 6. 1979
Acetylcholine receptor in myasthenia gravis: increased affinity for alpha-bungarotoxin.. 4. 1978
Cerebral hemodynamics and metabolism in pseudotumor cerebri.. 4. 1978
A prospective study of nontraumatic coma: methods and results in 310 patients.. 2. 1977
Resolving the role of the paramedian thalamus in forebrain arousal mechanisms.. 84. 2018
A proposed role for routine EEGs in patients with consciousness disorders.. 77. 2014
Somatic mitochondrial DNA mutations and parkinsonism.. 72. 2012
Have we finally identified an autoimmune demyelinating disease?. 67. 2010
Meeting rigorous statistical standards in case reports.. 64. 2008
Magnetoencephalography is not a substitute for intracranial electroencephalography.. 60. 2006
Preoperative response to levodopa is the best predictor of transplant outcome.. 55. 2004
Synovial fluid polymerase chain reaction as an aid to the diagnosis of central nervous system Whipple's disease.. 45. 1999
Diagnosis of malignant meningitis.. 39. 1996
Trial of immunosuppression in amyotrophic lateral sclerosis using total lymphoid irradiation.. 36. 1994
Baclofen-induced generalized nonconvulsive status epilepticus.. 36. 1994
Monoclonal gammopathy and neuropathy.. 31. 1992
Does a retrovirus cause amyotrophic lateral sclerosis?. 30. 1991
Diagnosis of amyotrophic lateral sclerosis.. 30. 1991
Cerebrospinal fluid monoamine metabolites in narcolepsy: reanalysis.. 25. 1989
Peripheral neuropathy, plasma cell dyscrasia, and hot blood.. 12. 1982
Reply: To PMID 25472885. 2015
Reply: To PMID 23943579. 2014
Boxing can be made safer. 2013
Botulinum toxin: time to call it quits? 2009
Evidence-based medicine vs medicine-based evidence. 2008
Malignant glioma: who benefits from adjuvant chemotherapy? 1999
Embolic Stroke of Unknown Source Clinical Trials and Advances in Research.. 88. 2020
Crisis Standard of Care: Management of Infantile Spasms during COVID-19.. 88. 2020
Building on NeuroNEXT: Next generation clinics to cure chronic neurological disability.. 82. 2017
Posterior medial corticothalamic connectivity and consciousness.. 72. 2012
Gender differences in pediatric stroke: is elevated testosterone a risk factor for boys?. 66. 2009
Natalizumab: a double-edged sword?. 66. 2009
Quantitative neuroimaging advances in the measurement of brain injury but not brain function in systemic lupus erythematosus.. 64. 2008
Another "Awakenings".. 62. 2007
cAMP response element binding protein family transcription factors: the Holy Grail of neurological therapeutics?. 56. 2004
Poison and antidote: a novel model to study pathogenesis and therapy of LHON.. 56. 2004
Cyclooxygenase-2 and stroke: the long and short of it.. 54. 2003
Ischemic stroke in cancer patients: A review of an underappreciated pathology. 2018
New perspectives on developing acute stroke therapy. 2003

VIVO Weill Cornell Medical College

Annals of neurology Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)